Stock Rich List
#2291 on the rich list of 14,644 insiders

Mark Coleman

Director at Axsome Therapeutics. Based in New York, New York.

$58.3M
in disclosed stock, +$130K (+0.22%) today
Live prices, last trade 3:10 PM ET
Rank
2291st of 14,644
Companies held
1
Largest holding
AXSM, 100.0% of total
Latest SEC filing
Jun 10, 2026

What the $58.3M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Axsome Therapeutics AXSM
Common Stock
Indirectly (see filing footnote)403,856$134.30$54.2M93.0%Form 4, Jun 8, 2026
Axsome Therapeutics AXSM
Common Stock
Directly30,389$134.30$4.1M7.0%Form 4, Jun 10, 2026

Share counts are the amounts Mark Coleman reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Jun 10, 2026SoldAXSM643$249.00$160KView
Jun 2, 2026SoldAXSM5,537$223.39$1.2MView
Jun 1, 2026SoldAXSM6,000$230.30$1.4MView
May 29, 2026SoldAXSM6,000$233.46$1.4MView
Feb 26, 2026SoldAXSM25,000$161.11$4.0MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
2288Constantine Iordanou
Director, Verisk Analytics. Jersey City, NJ
$58.4M−$280K (−0.48%)
2289Brendan Horgan
Chief Executive Officer, Sunbelt Rentals Holdings. Fort Mill, SC
$58.4M−$1.8M (−2.98%)
2290Daniel R. Feehan
Director, Enova International. Chicago, IL
$58.3M−$749K (−1.27%)
2291Mark Coleman
Director, Axsome Therapeutics. New York, NY
$58.3M+$130K (+0.22%)
2292William McCamey
Chief Financial Officer, Atlanticus Holdings. Atlanta, GA
$58.3M−$2.2M (−3.68%)
2293Anthony M. Tang
Vice Chairman, Cathay General Bancorp. Los Angeles, CA
$58.3M−$1.0M (−1.70%)
2294German Larrea Mota Velasco
CHAIRMAN OF THE BOARD, Southern Copper. Phoenix, AZ
$58.1M−$1.7M (−2.90%)

Other Axsome Therapeutics insiders

All AXSM insiders

Questions

How much stock does Mark Coleman own?

Mark Coleman holds $58,319,104 in listed stock based on SEC filings and current prices, mostly Axsome Therapeutics (AXSM). That ranks 2291st on the Stock Rich List.

Is this Mark Coleman's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Mark Coleman last buy or sell stock?

The most recent open-market trade on file is a sale of 643 AXSM shares on Jun 10, 2026 at $249.00.